How we work with investors

Numerous investors already work with the Access to Medicine Foundation to improve their knowledge of how pharmaceutical companies manage risks and opportunities related to access-to-medicine and antimicrobial resistance (AMR). As of January 2021, 100+ investors – together managing assets of more than USD 18 trillion – have signed the Access to Medicine Index Investor Statement and committed to using the research of the Access to Medicine Foundation in their investment analysis and engagements with companies.

Get in touch

Back to top |